The MEK5-ERK5 kinase axis controls lipid metabolism in small cell lung cancer
Le Cam, L
AffiliationPediatrics and Genetics, Stanford University
MetadataShow full item record
AbstractSmall cell lung cancer (SCLC) is an aggressive form of lung cancer with dismal survival rates. While kinases often play key roles driving tumorigenesis, there are strikingly few kinases known to promote the development of SCLC. Here we investigated the contribution of the MAP kinase module MEK5/ERK5 to SCLC growth. MEK5 and ERK5 were required for optimal survival and expansion of SCLC cell lines in vitro and in vivo. Transcriptomics analyses identified a role for the MEK5-ERK5 axis in the metabolism of SCLC cells, including lipid metabolism. In-depth lipidomics analyses showed that loss of MEK5/ERK5 perturbs several lipid metabolism pathways, including the mevalonate pathway that controls cholesterol synthesis. Notably, depletion of MEK5/ERK5 sensitized SCLC cells to pharmacological inhibition of the mevalonate pathway by statins. These data identify a new MEK5-ERK5-lipid metabolism axis that promotes the growth of SCLC.
CitationCristea S, Coles GL, Hornburg D, Gershkovitz M, Arand J, Cao S, et al. The MEK5-ERK5 kinase axis controls lipid metabolism in small cell lung cancer. Cancer Res. 2020.
- PB1 domains of MEKK2 and MEKK3 interact with the MEK5 PB1 domain for activation of the ERK5 pathway.
- Authors: Nakamura K, Johnson GL
- Issue date: 2003 Sep 26
- The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.
- Authors: Simões AE, Rodrigues CM, Borralho PM
- Issue date: 2016 Oct
- YAP promotes myogenic differentiation <i>via</i> the MEK5-ERK5 pathway.
- Authors: Chen TH, Chen CY, Wen HC, Chang CC, Wang HD, Chuu CP, Chang CH
- Issue date: 2017 Jul
- MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway.
- Authors: Sun W, Kesavan K, Schaefer BC, Garrington TP, Ware M, Johnson NL, Gelfand EW, Johnson GL
- Issue date: 2001 Feb 16
- Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.
- Authors: Zhou C, Nitschke AM, Xiong W, Zhang Q, Tang Y, Bloch M, Elliott S, Zhu Y, Bazzone L, Yu D, Weldon CB, Schiff R, McLachlan JA, Beckman BS, Wiese TE, Nephew KP, Shan B, Burow ME, Wang G
- Issue date: 2008